BSE: 1010

43779.56 156.86 (0.36%)

Near 52W High of ₹46018.05

BSE 01 Sep, 2025 3:59 PM (IST)

BSE Healthcare PB	6.5
BSE Healthcare PE	39.5
BSE Healthcare DIV	0.5
BSE Healthcare EPS	1,109.5

BSE Healthcare Corporate Filings & Announcements

Latest corporate announcements and filings from BSE Healthcare on BSE

Search Inside the pdf :

Fortis Healthcare Ltd.

01 Sep 2025, 11:18PM

924.65

1.44%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

The relevant disclosure is attached.

Fortis Healthcare Ltd.

01 Sep 2025, 10:57PM

924.65

1.44%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Disclosure with respect to Press Release "Fortis Healthcare expands NCR Presence" is attached.

Syngene International Ltd.

01 Sep 2025, 10:54PM

635.15

1.48%

Company Update

Syngene International Ltd - 539268 - Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance …

BSE India

Grant of Performance Share Units under Syngene Long-term Incentive Performance Share Plan 2023 ("Plan")

Global Health Ltd.

01 Sep 2025, 10:39PM

1396.00

1.60%

Company Update

Global Health Ltd - 543654 - Announcement Under Regulation 30 Of Listing Regulations

BSE India

It is hereby informed that the Noida Hospital of the Company has commenced its operations effective from today.

Narayana Hrudayalaya Ltd.

01 Sep 2025, 09:32PM

1785.20

1.79%

AGM

Narayana Hrudayalaya Ltd - 539551 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Voting results and scrutinizers report on the resolutions passed at the 25th Annual General Meeting held on August 29, 2025

Fortis Healthcare Ltd.

01 Sep 2025, 08:05PM

924.65

1.44%

Company Update

Fortis Healthcare Ltd - 532843 - Execution Of Sub-Lease Agreement With R.R. Lifesciences Pvt Ltd

BSE India

The relevant disclosure is attached.

AstraZeneca Pharma India Ltd.

01 Sep 2025, 08:01PM

8764.00

3.59%

Corp. Note

AstraZeneca Pharma India Ltd - 506820 - Disclosure under Regulation 30A of LODR

BSE India

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

Acutaas Chemicals Ltd.

01 Sep 2025, 07:56PM

1413.60

0.54%

Corp. Note

Acutaas Chemicals Ltd - 543349 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Business Responsibility and Sustainability Report for the FY 2024-25 is enclosed.

Aarti Drugs Ltd.

01 Sep 2025, 07:51PM

473.45

0.83%

Company Update

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation of newspaper advertisement regarding completion of dispatch of Annual Report for FY 2024-25 and Notice of 40th AGM of the Company

RPG Life Sciences Ltd.

01 Sep 2025, 07:38PM

2339.80

0.83%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the details of Analyst/Institutional Investors meet which will be participated by the Company is attached.

Is BSE Healthcare worth buying?

20 Votes:

Buy 85.0%

Sell 10.0%

Hold 5.0%